NFKB1 and Miyoshi myopathy: In accord with these findings, co-culture of MM cells with soluble factors (IL-6 or VEGF) or stromal cells failed to diminish TL/Btz toxicity, consistent with the regimen’s ability to disrupt alternative NF-κB pathway signaling.